New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
14:59 EDTESRX, INSYInsys sinks after analyst sees drug to be excluded from coverage
Shares of Insys Therapeutic (INSY) are falling after Cleveland Research indicated that its checks showed Express Scripts (ESRX) was looking to exclude Insys' Subsys from its list of covered drugs for 2015. Express Scripts is a pharmacy benefits manager. Subsys is intended to provide pain relief for cancer patients. In mid-afternoon trading, Insys tumbled 8% to $27.68.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
10:08 EDTESRXExpress Scripts calls active
Subscribe for More Information
February 1, 2016
08:14 EDTINSYInsys Therapeutics longer term outlook stable, says RBC Capital
After surveying 40 doctors, including nine who prescribed large amounts of Insys' Subsys, RBC Capital says that payor pushback on the drug is "limited," while 95% of all the doctors surveyed and 89% of the high prescribers "intend to write as many or more Subsys prescriptions this year" as last year. The firm thinks the stock's valuation is attractive following its 61% pullback since July. It trimmed its price target on the stock to $44 from $49 but keeps an Outperform rating. .
January 29, 2016
10:13 EDTESRXExpress Scripts to exclude Valeant's Glumetza from formulary
Subscribe for More Information
January 28, 2016
06:24 EDTESRXAnthem added to Focus List at Citi
Citi analyst Ralph Giacobbe added Anthem (ANTM) to his firm's Focus List. As Anthem and Express Scripts (ESRX) continue to negotiate their pharmacy benefits manager contract, the analyst sees UnitedHealth (UNH) as a potential alternative for Anthem. Regardless of the outcome, Anthem is in the "driver's seat for significant savings/upside," which is not reflected in the stock. Giacobbe tells investors in a research note. He keeps a Buy rating on the name with a $172 price target.
January 25, 2016
15:24 EDTESRXExpress Scripts off highs after Clinton tweets critical NPR report
Subscribe for More Information
12:57 EDTINSYInsys Therapeutics: Recent media reports' account of practices 'misleading'
Subscribe for More Information
10:27 EDTINSYOptions with increasing implied volatility: CLDX INSY SNDK
Subscribe for More Information
10:01 EDTINSYInsys finding 'new ways to mislead insurance companies,' SIRF says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use